NAMI
JANX icon

Nomura Asset Management International’s Janux Therapeutics JANX Stock Holding History

Nomura Asset Management International’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Hold
76,601
– – ﹤0.01% 1182
2026
Q1 		$1.06M Hold
76,601
– – ﹤0.01% 1095
2025
Q4 		$1.06M Buy
+76,601
New +$1.8M ﹤0.01% 1090

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Nomura Asset Management International's JANX Position: Q2 2026 in Review

Nomura Asset Management International held its Janux Therapeutics (JANX) position steady in Q2 2026 at 76,601 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Nomura Asset Management International first reported a position in JANX in Q4 2025 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Nomura Asset Management International held 76,601 shares of Janux Therapeutics worth $1.18M as of Q2 2026.
  • Nomura Asset Management International left its Janux Therapeutics share count unchanged in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1182 holding.
  • Nomura Asset Management International first reported a position in Janux Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.